NCT07233252
- Conditions
- Kidney-sparing, Nab-paclitaxel, PD-1 Inhibitor, +2 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
Clinical trial condition
Explore clinical trials studying Renal Pelvic Carcinoma. Study availability and eligibility vary by location and protocol.
NCT07233252
NCT06598761
NCT06652022